Amgen's leukemia drug Blincyto infringes patents owned by Germany's Lindis Biotech, a Delaware federal jury said in a verdict ...

We recently compiled a list of the 10 Dogs of the Dow Dividend Stocks to Invest in. In this article, we are going to take a ...

Shares of Amgen Inc. AMGN slumped 0.21% to $265.95 Tuesday, on what proved to be an all-around dismal trading session for the ...

Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

The drug manufacturer Amgen announced Thursday it will invest another $1 billion and add 370 jobs to its future facility in ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Amgen, a biotechnology company, announced last week that it will invest $1 billion in expanding its manufacturing facility in ...

One of the world's largest pharmaceutical companies is planning a major expansion in Wake County. Amgen (Nasdaq: AMGN) is ...

Wells Fargo analyst Derek Archila maintained a Buy rating on Viridian Therapeutics (VRDN – Research Report) yesterday and set a price target of ...

Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have been given an average rating of “Hold” by the twenty-six analysts ...

The most recent trading session ended with Amgen (AMGN) standing at $273.41, reflecting a -0.85% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which ...